Correlation Between Checkpoint Therapeutics and Equillium
Can any of the company-specific risk be diversified away by investing in both Checkpoint Therapeutics and Equillium at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Checkpoint Therapeutics and Equillium into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Checkpoint Therapeutics and Equillium, you can compare the effects of market volatilities on Checkpoint Therapeutics and Equillium and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Checkpoint Therapeutics with a short position of Equillium. Check out your portfolio center. Please also check ongoing floating volatility patterns of Checkpoint Therapeutics and Equillium.
Diversification Opportunities for Checkpoint Therapeutics and Equillium
-0.12 | Correlation Coefficient |
Good diversification
The 3 months correlation between Checkpoint and Equillium is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Checkpoint Therapeutics and Equillium in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Equillium and Checkpoint Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Checkpoint Therapeutics are associated (or correlated) with Equillium. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Equillium has no effect on the direction of Checkpoint Therapeutics i.e., Checkpoint Therapeutics and Equillium go up and down completely randomly.
Pair Corralation between Checkpoint Therapeutics and Equillium
Given the investment horizon of 90 days Checkpoint Therapeutics is expected to generate 0.67 times more return on investment than Equillium. However, Checkpoint Therapeutics is 1.48 times less risky than Equillium. It trades about 0.06 of its potential returns per unit of risk. Equillium is currently generating about 0.03 per unit of risk. If you would invest 231.00 in Checkpoint Therapeutics on September 12, 2024 and sell it today you would earn a total of 170.00 from holding Checkpoint Therapeutics or generate 73.59% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Checkpoint Therapeutics vs. Equillium
Performance |
| Timeline |
| Checkpoint Therapeutics |
| Equillium |
Checkpoint Therapeutics and Equillium Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Checkpoint Therapeutics and Equillium
The main advantage of trading using opposite Checkpoint Therapeutics and Equillium positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Checkpoint Therapeutics position performs unexpectedly, Equillium can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Equillium will offset losses from the drop in Equillium's long position.| Checkpoint Therapeutics vs. Equillium | Checkpoint Therapeutics vs. DiaMedica Therapeutics | Checkpoint Therapeutics vs. Valneva SE ADR | Checkpoint Therapeutics vs. Vivani Medical |
| Equillium vs. Lyra Therapeutics | Equillium vs. Hookipa Pharma | Equillium vs. Jasper Therapeutics | Equillium vs. Cingulate Warrants |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |